Jacob King - WPA Pool/Getty Images
© 2024 Blaze Media LLC. All rights reserved.
Moderna seeks green light from FDA on fourth COVID-19 vaccine shot
March 17, 2022
Moderna is asking the U.S. Food and Drug Administration to give the green light for another booster shot of its COVID-19 vaccine.
A press release noted that Moderna is seeking "an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines."
"The request to include adults over 18 years of age was made to provide flexibility for the U.S. Centers for Disease Control and Prevention (CDC) and healthcare providers to determine the appropriate use of an additional booster dose of mRNA-1273, including for those at higher risk of COVID-19 due to age or comorbidities," the company noted.
Pfizer and BioNTech recently announced that they submitted an application to the FDA seeking emergency use authorization for another COVID-19 vaccine booster shot for individuals 65 and older.
Currently, the protocol for most people who get the Pfizer or Moderna vaccines is to receive two shots for their primary series and one booster shot. But the CDC indicates that immunocompromised individuals ages 12 and older should get three shots for their primary series, plus a booster shot. The Moderna vaccine is currently only cleared for use in adults.
The COVID-19 vaccine shots could become a yearly experience. Recently, when Pfizer CEO Albert Bourla was asked whether he thinks people will need to prepare to get the shot annually, he replied, "I think so."
Pfizer CEO Albert Bourla on “Face the Nation” | Full interviewyoutu.be
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
Alex Nitzberg is a staff writer for Blaze News.
alexnitzberg
more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.